Benralizumab as a Potential Adjunctive Therapy in Eosinophilic Granulomatosis With Polyangiitis

被引：4
|
作者：
Lee, Yvonne [1 ]
Hojjati, Mehrnaz [2 ]
机构：
[1] Loma Linda Univ, Med Ctr, Dept Internal Med, Loma Linda, CA 92350 USA
[2] Loma Linda Univ, Med Ctr, Dept Rheumatol, Loma Linda, CA USA
来源：
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2021年 / 27卷 / 8S期
关键词：
MEPOLIZUMAB;
D O I：
10.1097/RHU.0000000000001419
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S401 / S402
页数：2
相关论文
共 50 条
  • [1] Benralizumab in eosinophilic granulomatosis with polyangiitis
    Laorden, Daniel
    Romero, David
    Dominguez-Ortega, Javier
    MEDICINA CLINICA, 2022, 158 (10): : 441 - +
  • [2] Benralizumab in Eosinophilic Granulomatosis with Polyangiitis
    Cottu, Adrien
    Groh, Matthieu
    Desaintjean, Charlene
    Marchand-Adam, Sylvain
    Guillevin, Loic
    Puechal, Xavier
    Lazaro, Estibaliz
    Samson, Maxime
    Taille, Camille
    Durel, Cecile-Audrey
    Diot, Elisabeth
    Nicolas, Sarah
    Guilleminault, Laurent
    Ebbo, Mikael
    Cathebras, Pascal
    Dupin, Clairelyne
    Yildiz, Halil
    Belfeki, Nabil
    Pugnet, Gregory
    Chauvin, Pierre
    Jouneau, Stephane
    Lifermann, Francois
    Martellosio, Jean-Philippe
    Cottin, Vincent
    Terrier, Benjamin
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1351 - 1354
  • [3] Benralizumab in eosinophilic granulomatosis with polyangiitis
    Laorden, Daniel
    Romero, David
    Dominguez-Ortega, Javier
    MEDICINA CLINICA, 2022, 158 (09): : 441 - 442
  • [4] Benralizumab for eosinophilic granulomatosis with polyangiitis
    Cottu, Adrien
    Groh, Matthieu
    Desaintjean, Charlene
    Marchand-Adam, Sylvain
    Guillevin, Loic
    Puechal, Xavier
    Beaumesnil, Stacy
    Lazaro, Estibaliz
    Samson, Maxime
    Taille, Camille
    Durel, Cecile-Audrey
    Diot, Elizabeth
    Nicolas, Sarah
    Guilleminault, Laurent
    Ebbo, Mikael
    Cathebras, Pascal
    Dupin, Clairelyne
    Yildiz, Halil
    Belfeki, Nabil
    Pugnet, Gregory
    Chauvin, Pierre
    Jouneau, Stephane
    Lifermann, Francois
    Martellosio, Jean-Philippe
    Cottin, Vincent
    Terrier, Benjamin
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (12) : 1580 - 1586
  • [5] Benralizumab in cases of eosinophilic granulomatosis with polyangiitis
    Carrette, A.
    Mercier, V
    Lelubre, C.
    Peche, R.
    REVUE DES MALADIES RESPIRATOIRES, 2022, 39 (07) : 621 - 625
  • [6] Successful benralizumab for eosinophilic myocarditis in eosinophilic granulomatosis with polyangiitis
    Belfeki, N.
    Abroug, S.
    Ghriss, N.
    Chouchane, I
    Hamrouni, S.
    Strazzulla, A.
    Zayet, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (04) : 834 - 837
  • [7] Early benralizumab for eosinophilic myocarditis in eosinophilic granulomatosis with polyangiitis
    Colantuono, Stefania
    Pellicano, Chiara
    Leodori, Giorgia
    Cilia, Francesco
    Francone, Marco
    Visentini, Marcella
    ALLERGOLOGY INTERNATIONAL, 2020, 69 (03) : 483 - 484
  • [8] Eosinophilic granulomatosis with polyangiitis successfully treated with benralizumab
    Chica-Guzman, Maria Vanessa
    Morillo-Guerrero, Raquel
    Carron-Herrero, Alejandra
    Gonzalez-de-Olano, David
    Almonacid-Sanchez, Carlos
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (02) : 228 - 230
  • [9] Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis
    Sun, Ryan
    Wei, Lee-Jen
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (20):
  • [10] Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis
    Wechsler, Michael E.
    Nair, Parameswaran
    Terrier, Benjamin
    Walz, Bastian
    Bourdin, Arnaud
    Jayne, David R. W.
    Jackson, David J.
    Roufosse, Florence
    Boerjesson Sjoe, Lena
    Fan, Ying
    Jison, Maria
    Mccrae, Christopher
    Necander, Sofia
    Shavit, Anat
    Walton, Claire
    Merkel, Peter A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (10): : 911 - 921
12345